Who Is Scott Adams and Why Is He Asking Trump to ‘Save My Life’? Pluvicto Drug Issue Explained

Dilbert creator Scott Adams has publicly appealed to former U.S. President Donald Trump for help as he faces a life-threatening stage of prostate cancer. Adams, who revealed that he is battling metastasized prostate cancer, says delays in receiving a vital drug called Pluvicto could cost him his life.

In a post on X (formerly Twitter), Adams said he would reach out directly to Trump, who had previously offered to help him during his illness. Within hours, several figures associated with the Trump administration, including Health Secretary Robert F. Kennedy Jr. and White House Deputy Chief of Staff Dan Scavino Jr., responded, assuring Adams that they were working on the issue.

Scott Adams’ Plea to Donald Trump

Scott Adams wrote, “On Monday, I will ask President Trump, via X, to help save my life. He offered to help me if I needed it. I need it.” The post drew wide attention online, prompting swift responses from political figures and health officials connected to the Trump campaign and administration.

Adams explained that his healthcare provider, Kaiser Permanente of Northern California, had approved his application to receive Pluvicto, a cutting-edge cancer treatment. However, he claimed the facility “dropped the ball” in scheduling the intravenous (IV) session required to administer the medication. “I can’t seem to fix that,” he said, adding that he was “declining fast.”

Trump later shared Adams’ post on Truth Social, replying, “On it.” Trump’s son, Donald Trump Jr., also shared the post, saying he would ensure his father saw it. Health Secretary Kennedy Jr. commented, “Scott. How do I reach you? The President wants to help.”

What Is Pluvicto and Why Is It Important?

Pluvicto, or lutetium Lu 177 vipivotide tetraxetan, is a prescription radioligand therapy approved by the U.S. Food and Drug Administration (FDA) in 2022. It is used to treat prostate-specific membrane antigen (PSMA)–positive metastatic castration-resistant prostate cancer (mCRPC) in adults. The treatment is administered intravenously and designed to target and destroy prostate cancer cells expressing the PSMA biomarker.

Unlike traditional radiation therapy, Pluvicto uses targeted radioactivity to attach to cancerous cells, delivering radiation from within while minimizing damage to surrounding healthy tissue. It has shown promising results in extending the lives of patients who have exhausted conventional treatments such as chemotherapy and hormone therapy.

Adams’ frustration stems from delays in scheduling the infusion needed to receive the medication. “That will give me a fighting chance to stick around on this planet a little bit longer,” he wrote, emphasizing that while the drug is not a cure, it has produced “good results for many people.”

Who Is Scott Adams?

Scott Adams is best known as the creator of the popular workplace comic strip Dilbert, which gained massive popularity in the 1990s for its satirical take on corporate culture. He has also authored several books, including Loserthink and God’s Debris. Over the years, Adams has become a polarizing figure due to his political commentary, especially his outspoken support for Donald Trump during the 2016 election.

In 2016, Adams predicted Trump’s presidential victory and gained notoriety for his commentary on persuasion and political strategy. However, some of his later remarks on social and political issues drew widespread criticism and led to the cancellation of his syndicated comic strip in multiple newspapers.

Public and Political Reactions

Adams’ plea sparked immediate political and public reactions. Figures close to Trump quickly coordinated responses, including Dr. Mehmet Oz, who currently oversees the Centers for Medicare & Medicaid Services (CMS). Trump’s online repost suggested he was directly intervening to ensure Adams receives timely access to Pluvicto treatment.

The situation also renewed public discussion about healthcare access, treatment delays, and the role of political influence in emergency medical situations. Many online commenters expressed sympathy for Adams while also criticizing systemic inefficiencies in major healthcare providers like Kaiser Permanente.

As of now, Adams has not confirmed whether his Pluvicto treatment has been scheduled, but his post has reignited debate on the accessibility of advanced cancer therapies for American patients.

FYI (keeping you in the loop)-

Q1: Who is Scott Adams?

Scott Adams is the creator of the comic strip Dilbert and an author known for his commentary on politics and corporate culture.

Q2: Why is Scott Adams asking Donald Trump for help?

Adams is seeking Trump’s help to expedite his access to the cancer drug Pluvicto after delays by his healthcare provider.

Q3: What is the Pluvicto drug?

Pluvicto is an FDA-approved radioligand therapy used for treating advanced prostate cancer that is resistant to standard treatments.

Q4: What has Donald Trump said about Scott Adams’ case?

Trump shared Adams’ post on Truth Social, writing that he was “on it,” signaling he would help coordinate a response.

Q5: How effective is Pluvicto for prostate cancer?

Clinical results show that Pluvicto can improve survival rates and quality of life in advanced prostate cancer patients, though it is not a cure.